IMS To Work with Pharma Association

IMS Health has announced an exclusive data and knowledge sharing agreement with the European Generic medicines Association (EGA). IMS will provide sales info from its MIDAS database, which tracks 90% of prescription drug sales in more than 80 countries, plus expert opinion, in return for access to EGA information and expertise.

The EGA is the official representative body of the European generic pharmaceuticals industry and represents more than 500 companies and their subsidiaries throughout Europe. As part of the agreement, the two organizations will work together to ensure that IMS's standard classifications of generic products remain optimal and relevant to the pharmaceutical industry.

Gilles Pajot, President of IMS European Region, says the new collaboration will help provide generic clients in Europe with innovative offerings, and give the EGA 'access to third-party, independent data and advice needed to support its critical consultative role in European healthcare policy-making. The result will be greater access to accurate, standardized and timely generics information, which will strengthen working relationships among all generic stakeholders'.

According to Greg Perry, the EGA's Director General, 'This agreement with IMS will enhance our ability to play an effective part in the European healthcare policy decision-making process and underline the great importance of generic medicines. We continue to work closely with European national governments and EU institutions to develop affordable solutions for pharmaceutical care, and IMS's insights and data will help us strengthen Europe's competitive position within the global pharmaceutical medicines market'.

IMS' web site is at www.imshealth.com

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• All news